Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The procedure described by CPT® Code 92995 refers to a percutaneous transluminal coronary atherectomy, which is a minimally invasive technique used to remove plaque buildup from the coronary arteries. This procedure can be performed using mechanical methods or other techniques, and it may be accompanied by balloon angioplasty, which involves the use of a balloon catheter to further open the artery. The access point for this procedure is typically through the femoral artery, where the skin is prepared, and a needle is used to puncture the artery, allowing for the insertion of a sheath. A guidewire is then navigated through the aorta and into the affected coronary artery, which is often occluded due to plaque accumulation. During the atherectomy, a specialized balloon catheter equipped with a cutting piston is utilized to shave away the plaque from the arterial wall. This cutting action allows the plaque to be collected into the device for removal once the procedure is completed. The physician may perform multiple passes with the atherectomy device to ensure thorough plaque removal. After the atherectomy, a balloon-tipped angioplasty catheter may be introduced to the blockage site, where it is inflated to compress any residual plaque and smooth the artery's interior. Finally, contrast dye is injected, and completion angiography is conducted to confirm that the treated artery remains open and patent. This procedure is specifically coded as 92995 for a single coronary artery, while 92996 is designated for atherectomy of each additional coronary artery.
© Copyright 2026 Coding Ahead. All rights reserved.
The percutaneous transluminal coronary atherectomy procedure is indicated for patients who present with significant coronary artery disease characterized by the presence of atherosclerotic plaque that obstructs blood flow in the coronary arteries. This condition may lead to symptoms such as angina pectoris, myocardial ischemia, or other cardiovascular complications. The procedure is typically considered when non-invasive treatments have been insufficient, and there is a need to restore adequate blood flow to the heart muscle.
The procedure begins with the preparation of the access site, typically the femoral artery, where the skin is cleaned and sterilized. A needle is then used to puncture the artery, and a sheath is inserted to facilitate access. Following this, a guidewire is carefully advanced through the sheath, navigating through the aorta and into the blocked coronary artery. Once the guidewire is in place, the atherectomy device, which includes a specialized balloon catheter with a cutting piston, is introduced. The cutting piston is designed to shave away the plaque from the arterial wall as it is advanced. The physician may perform multiple passes with the atherectomy device to ensure that sufficient plaque is removed to restore blood flow. As the plaque is shaved off, it is collected into the nose of the atherectomy device for removal at the end of the procedure. After the atherectomy is completed, a balloon-tipped angioplasty catheter is advanced to the site of the blockage. The balloon is inflated to compress any remaining plaque and smooth the arterial wall, further enhancing blood flow. Once the angioplasty is completed, the catheter is withdrawn, and contrast dye is injected into the artery. A completion angiography is then performed to verify that the treated artery is patent and that blood flow has been adequately restored.
After the completion of the percutaneous transluminal coronary atherectomy, patients are typically monitored for any immediate complications, such as bleeding or vascular injury at the access site. Recovery may involve a short hospital stay, during which vital signs and heart function are closely observed. Patients may be advised to rest and limit physical activity for a specified period to allow for healing. Follow-up appointments are essential to assess the success of the procedure and to monitor for any potential recurrence of symptoms or complications. Additionally, patients may be prescribed medications to manage their cardiovascular health and prevent future blockages.
| Short Descr | CORONARY ATHERECTOMY | Medium Descr | CORONARY ATHERECTOMY | Long Descr | Percutaneous transluminal coronary atherectomy, by mechanical or other method, with or without balloon angioplasty; single vessel | Status Code | Active Code | Global Days | 000 - Endoscopic or Minor Procedure | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 45 - Percutaneous transluminal coronary angioplasty (PTCA) |
Get instant expert-level medical coding assistance.